Engineering solutions provider CSC Holdings has secured foundation contracts with a toal value exceeding $150 million since its FY2025 beginning Apr 1.
As at Aug 31, CSC’s order book stands at around $320 million, with the bulk of orders to be delivered within the next 12 months.
These includes industrial projects such as AbbVie’s biologics manufacturing facility expansion in Tuas Biomedical Park, a new 300 milimetre semiconductor wafer manufacturing facility located along Tampines Industrial Avenue 1, and a two-year term contract for geophysical and survey works for JTC estates.
Commercial projects include a residential and commercial integrated development at Tampines Avenue 11 and the redevelopment of Central Mall properties into mixed-use development comprising commercial, hotel and serviced apartments around the Singapore River Planning Area.
These also include an institutional project for the Bidadari Polyclinic and Nursing Home at Alkaff Crescent, and an infrastructure project for a warehouse building for PSA Supply Chain Hub at Tuas Port.
Lastly, there are also a number of residential projects, such as Housing Development Board (HDB) residential developments of 739 units along Jalan Rajah and1,026 units in Punggol West, and a condominium development of 794 units in Setapak, Kuala Lumpur, Malaysia.
See also: Interra Resources granted 12-month extension to meet SGX watch-list exit requirements
These contracts are expected to contribute positively to CSC’s FY2025 results for financial year ending 31 March 2025
Shares in CSC Holdings closed flat at 0.7 cents on Sept 6.
